BNP/CALL/SARTORIUS STEDIM BIO/220/0.01/20.09.24 Stock

Warrant

DE000PC1ME57

Market Closed - Börse Stuttgart 03:23:22 2024-06-07 am EDT
0.066 EUR -2.94% Intraday chart for BNP/CALL/SARTORIUS STEDIM BIO/220/0.01/20.09.24
Current month+8.20%
1 month-63.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 0.066 -2.94%
24-06-06 0.068 +25.93%
24-06-05 0.054 -3.57%
24-06-04 0.056 -16.42%
24-06-03 0.067 +9.84%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 03:23 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1ME5
ISINDE000PC1ME57
Date issued 2023-12-11
Strike 220
Maturity 2024-09-20 (105 Days)
Parity 100 : 1
Emission price 0.23
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.73
Lowest since issue 0.054
Delta0.29x
Omega 7.394
Premium23.07x
Gearing25.47x
Moneyness 0.8393
Difference Strike 35.35
Difference Strike %+16.07%
Spread 0.019
Spread %23.17%
Theoretical value 0.0725
Implied Volatility 45.38 %
Total Loss Probability 78.70 %
Intrinsic value 0.000000
Present value 0.0725
Break even 227.25 €
Theta-0.01x
Vega0x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
184.6 EUR
Average target price
248.8 EUR
Spread / Average Target
+34.76%
Consensus